Join the National Foundation for Infectious Diseases (NFID) for a 1.5 hour webinar discussion highlighting the importance of immunization to help protect against severe illness during the upcoming respiratory season. Speakers will discuss current US immunization recommendations for COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease, and will provide strategies to increase immunization rates.
NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, will moderate the discussion with NFID Director Matthew M. Zahn, MD, Pediatric Infectious Disease Physician at Rady Children’s Health, Melody Butler, RN, BSN, CIC, Founding Executive Director and President of Nurses Who Vaccinate and Director of Infection Prevention and Control at Stony Brook Southhampton Hospital, and Brigid K. Groves, PharmD, MS, Vice President of Professional Affairs at the American Pharmacists Association (APhA).
Al finalizar la actividad, los participantes serán capaces de:
- Discuss current evidence-based recommendations for COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease immunization in the US
- Describe the burden of COVID-19, flu, RSV, and pneumococcal disease in the US
- Implement communication strategies to help increase respiratory disease immunization rates in the US
La participación en esta actividad es gratuita, pero se requiere inscripción previa:
La National Foundation for Infectious Diseases (NFID) está acreditada por el Consejo de Acreditación para la Educación Médica Continua (ACCME) para proporcionar educación médica continua a los médicos.
La NFID designa esta actividad en vivo por un máximo de 1.5 créditos de categoría 1 de AMA PRA™. Los médicos deben reclamar solo los créditos proporcionales al grado de su participación en la actividad.